Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Ace5858
    Junior Member
    • Mar 2012
    • 8

    #1

    Sequencing NYC Subway bacteria????

    Hello fellow researchers!

    I have an exciting and ambitious project to present.

    My name is Jorge Gandara. I'm the wetlab manager for the research lab of Dr. Christopher Mason at Weill Cornell Medical College in New York City. Our website is www.masonlab.net

    We are currently embarking on an ambitious project here in New York City. We have just taken swab samples at EVERY subway station in the NYC Subway system. Our goal is to extract DNA from all the bacteria we find and run the sequencing data through MetaPhlAn to find all the bacteria and microbiomes found at all the stations. Ergo...a Pathomap!

    Our team have just taken over 1400 swab samples from every stop and are currently extracting and sequencing DNA from all the samples.

    Between the staff, the swabs, the subway metrocards, the extraction/sequencing reagents, it's a very pricey project.

    We have recently opened an indiegogo account and are looking for donations towards our project. We have some very awesome gifts for each level of donation. Want to know what types of bacteria are in your home? We'll sequence the DNA for you!

    Here's the website: http://www.indiegogo.com/projects/pa...opic-residents

    Please donate and help us out. Thanks so much!!!

Latest Articles

Collapse

  • SEQadmin2
    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
    by SEQadmin2



    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

    Despite this, “CRISPR helped turn genome editing from a specialized technique into
    ...
    07-31-2026, 11:01 AM
  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 07:41 AM
0 responses
12 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-03-2026, 10:13 AM
0 responses
25 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-31-2026, 02:55 AM
0 responses
39 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-24-2026, 12:17 PM
0 responses
25 views
0 reactions
Last Post SEQadmin2  
Working...